Temazepam
The active substance of Teseda is temazepam. Temazepam is a benzodiazepine. This medicine has anxiolytic (anti-anxiety) and sedative (sleep-inducing) properties.
Teseda is used for the short-term treatment of severe anxiety that impairs the patient's functioning, or for the treatment of insomnia in adults.
Before starting to take Teseda, discuss it with your doctor or pharmacist, as you may experience:
Teseda may cause physical and psychological dependence. Patients with a history of alcohol or drug dependence should be aware of the possible symptoms of dependence (including headache, muscle pain, anxiety, confusion, irritability). If necessary, contact your doctor.
Do not use this medicine in children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take, including those available without a prescription and herbal medicines.
When taken together, the effect of Teseda or other medicines may be altered or side effects may occur. These medicines include:
Taking Teseda with opioids (strong painkillers, medicines used for substitution therapy for addiction, and some cough medicines) increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can be life-threatening.
Therefore, concurrent use should only be considered when other treatment methods are not possible.
If your doctor has prescribed Teseda with opioids, use the smallest effective dose, and the duration of treatment should be as short as possible.
Tell your doctor about all opioid medicines you are taking and follow the dosage instructions carefully. It may be helpful to inform friends or family about the risk, so they are aware of the symptoms. If these symptoms occur, contact your doctor.
If you are scheduled for surgery under anesthesia, tell your doctor that you are taking Teseda.
Remember to tell your doctor that you are taking Teseda during follow-up visits.
Take Teseda tablets with a glass of water or other liquid. Tablets can be taken with or without food.
It is not recommended to consume alcohol while taking this medicine, as the sedative effect on the central nervous system may be increased when temazepam and alcohol are taken together.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor for advice before taking this medicine. Do not take Teseda during pregnancy and breastfeeding.
If you become pregnant during treatment with Teseda, tell your doctor immediately, as they may decide to change the treatment.
Teseda causes drowsiness and reduces the ability to drive and perform tasks that require precision, especially at the beginning of treatment. Therefore, avoid driving and performing precise tasks until you know how the medicine affects you.
A dose (10 mg or 20 mg) taken in the evening usually does not affect performance the next morning.
Each tablet contains 72.3 mg of lactose monohydrate.
If you have been diagnosed with an intolerance to some sugars, contact your doctor before taking the medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The dividing line on the tablet is only to facilitate breaking the tablet to make it easier to swallow.
The duration of treatment should be as short as possible. Long-term use of Teseda may lead to dependence or the development of tolerance to the medicine (reduced effectiveness of Teseda).
Insomnia
The recommended dose is 10 mg - 20 mg per day, before bedtime. The recommended dose for elderly patients is 10 mg per day. The dose should be taken directly before bedtime. After taking the medicine, the patient should have 7-8 hours of uninterrupted sleep.
The duration of treatment should be only a few days to two weeks and should not exceed 4 weeks (including the period of dose reduction).
Periodic anxiety states
The recommended dose is 10 mg - 30 mg, no more than three times a day. The duration of treatment should not exceed 8 to 12 weeks (including the period of dose reduction).
If you have taken too many tablets by mistake, temazepam may cause central nervous system depression. Symptoms may include drowsiness, disorientation, weakness, lack of coordination or muscle tension, decreased body temperature, decreased blood pressure, breathing difficulties, coma, and in rare cases, death.
When going to the doctor or hospital, take the package of medicine with you.
Take the missed dose as soon as possible. However, if it is almost time for the next dose, do not take the missed dose.
Do not take a double dose to make up for the missed dose.
Do not stop taking the medicine suddenly, as unexpected withdrawal symptoms may occur. These symptoms include feelings of anxiety, fear, or nervousness (anxiety), insomnia, and seizures. The dose of the medicine should be gradually reduced.
Stopping treatment with Teseda may also lead to temporary insomnia and anxiety (rebound phenomenon). Mood changes and restlessness may also occur. To avoid these symptoms, the dose of the medicine should be gradually reduced, according to the doctor's instructions.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Teseda can cause side effects, although not everybody gets them.
If you experience any of the following symptoms of a severe allergic reaction, stop treatment and contact your doctor (very rare: may affect up to 1 in 10,000 people):
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people):
Long-term use of Teseda may lead to the development of tolerance and dependence.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301; fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 25°C. Store the blister in the outer packaging to protect from light.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after the words "Expiry date (EXP)". The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
White to light yellow, round, approximately 7 mm in diameter, flat, uncoated tablets with a dividing line, marked with ORN73.
Pack sizes: 20 tablets
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.